Endo Stock Quote ENDP - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.2926

Bid

0.29

Ask

0.294

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

68.825M

Previous Close

0.2926

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

235,220,000

Dividend Yield

PE Ratio

-0.03

Earnings Per Share (EPS)

-10.42

Revenue

2.01B

Net Profit

-2.45B

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceut... Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL. The majority of its revenue comes from the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.endo.com

Headquarters

Dublin, Irl

Founded

Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting

Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting PR Newswire DUBLIN, Sept. 21, 2023 DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Endo International plc (OTC:...

ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS

ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS PR Newswire DUBLIN, Aug. 8, 2023 DUBLIN, Aug. 8, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today reported financial results for...

Endo Launches Bivalirudin Injection in Ready-to-Use Vials

Endo Launches Bivalirudin Injection in Ready-to-Use Vials PR Newswire DUBLIN, July 18, 2023 Only ready-to-use liquid format of bivalirudin on the marketDoes not require reconstitution, dilution...

Endo Presents New Data at the American Podiatric Medical Association Annual Meeting

Endo Presents New Data at the American Podiatric Medical Association Annual Meeting PR Newswire DUBLIN, July 13, 2023 DUBLIN, July 13, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ...

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire DUBLIN...

ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS

ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS PR Newswire DUBLIN, May 8, 2023 DUBLIN, May 8, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	$ 8.26 (89.02%)	2.03M
XCURExicure Inc	$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	$ 0.0201 (-0.50%)	415.87M
NVDANVIDIA Corporation	$ 141.95 (-3.22%)	229.93M
SMCISuper Micro Computer Inc	$ 33.15 (11.62%)	155.43M
VRPXVirpax Pharmaceuticals Inc	$ 0.5501 (-6.72%)	154.17M
SOUNSoundHound AI Inc	$ 8.24 (18.05%)	103.6M